DOI: 10.1055/s-00023610

Drug Research

LinksSchließen

Referenz

Tanizawa Y, Kaku K, Araki E. et al.
Long-term safety and efficacy of tofogliflozin, a selective inhibitor of sodium-glucose cotransporter 2, as monotherapy or in combination with other oral antidiabetic agents in Japanese patients with type 2 diabetes mellitus: multicenter, open-label, randomized controlled trials.

Expert Opin Pharmacother 2014;
15: 749-766

Bibliographische Angaben herunterladen

Aufrufen in:
Aufrufen in:
Aufrufen in: